Pascal Johann

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 14, 2026
CpG hypermethylation and WNT/AP-1 cooperativity define the epigenetic landscape and a clinical subgroup of high-risk pediatric adrenocortical carcinoma.

|Jun 24, 2026
Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study Group.

|Oct 31, 2025
Multi-modal omics analysis of a paediatric melanoma highlights mechanisms underlying treatment resistance.

Marlena Mucha, Sebastian Bühner, Maurice Loßner

|Aug 09, 2024
Clinical and Molecular Risk Factors in Extracranial Malignant Rhabdoid Tumors: Toward an Integrated Model of High-Risk Tumors.

Victoria E Fincke, Mona Steinbügl, Hye-Jung E Chun

|Jul 08, 2021
The drug development pipeline for glioblastoma-A cross sectional assessment of the FDA Orphan Drug Product designation database.

Pascal Johann, Dominic Lenz, Markus Ries

|Apr 21, 2020
Invited Review: Dysregulation of chromatin remodellers in paediatric brain tumours - SMARCB1 and beyond.

P D Johann

Pageof 2

Frequent Collaborators

3 joint publications

Marlena Mucha

3 joint publications

Michael C Frühwald

2 joint publications

Victoria E Fincke

2 joint publications

Nic G Reitsam